image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Pets at Home

August 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PETS
  • Price:
  • 358p
Pets at Home reported final results for the year ended March modestly ahead of forecasts and supported by a strong Q4. Net cash of £55m was also ahead of expectations and has supported an increased dividend and planned £50m share buyback. The big news is that management has launched a new five year plan for sales and pretax profit to increase at a compound average growth of 7% and 10%, respectively (FY’23-’28), which implies an acceleration in PBT growth beyond FY’24. Results themselves showed revenues up 6.6% year-on-year to £1,404m with pretax profit up almost 5% to £136.4m. Over the last five years Pets at Home has increased market share by 6% to 24% and in spite of the cost of living crisis, last year showed further pro ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X